At AAIC 2026, the head of sciences at the Alzheimer’s Center in Amersterdam discusses the growing role of biomarkers in understanding the biological complexity of Alzheimer disease and advancing more personalized approaches to diagnosis and treatment. [WATCH TIME: 3 minutes]